AI maps psychedelic ‘trip’ to specific regions of the brain
Mapping these diverse and wildly subjective psychedelic experiences could open up new routes to psychiatric treatments.
Mapping these diverse and wildly subjective psychedelic experiences could open up new routes to psychiatric treatments.
For many years, drugs such as LSD, psilocybin and Dimethyltryptamine (DMT) were viewed only as highly dangerous drugs. However, in recent years they have had
Subscribe to Reaction and receive unlimited access to the site, our daily email with analysis every evening and invites to online events.
© Copyright 2024 Reaction Digital Media Limited – All Rights Reserved. Registered Company in England & Wales – Company Number: 10166531.